Comparison between mesothelin and fibulin-3 detection in pleural malignant mesothelioma (MPM) patients

被引：0
|
作者：
Pinelli, Valentina
Fini, Donatella
Battolla, Enrico
Ferro, Paola
Franceschini, Maria Cristiana
Fontana, Vincenzo
Pistillo, Maria Pia
Roncella, Silvio
Canessa, Pier Aldo
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2016年 / 48卷
关键词：
Mesothelioma; Pleura; Biomarkers;
D O I：
10.1183/13993003.congress-2016.PA5075
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA5075
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Diagnostic value of fibulin-3 for malignant pleural mesothelioma: A systematic review and meta-analysis
    Ren, Ran
    Yin, Pengpeng
    Zhang, Yan
    Zhou, Jianyun
    Zhou, Yixing
    Xu, Rufu
    Lin, Hai
    Huang, Chunji
    ONCOTARGET, 2016, 7 (51) : 84851 - 84859
  • [22] Mesothelin is a biomarker of tumor aggressiveness and therapy response in malignant pleural mesothelioma (MPM)
    Servais, Elliot L.
    Colovos, Christos
    Suzuki, Kei
    Velez, Marissa
    Rodriguez, Luis
    Sima, Camelia
    Rusch, Valerie W.
    Sadelain, Michel
    Adusumilli, Prasad S.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2010, 211 (03) : S36 - S36
  • [23] Fibulin-3 as a biomarker for mesothelioma
    Burki, Talha Khan
    LANCET ONCOLOGY, 2012, 13 (11): : E469 - E469
  • [24] Dysphagia in Patients with Malignant Pleural Mesothelioma (MPM)
    Malec, M.
    Desai, A.
    Waxman, I.
    Karrison, T.
    Rose, B.
    Mendoza, A.
    Gadiraju, M.
    Straus, C.
    Churpek, J.
    Kindler, H.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S759 - S760
  • [25] Is IHC for Fibulin-3 Specific for Malignant Mesothelioma in Effusion Cytology?
    Velosa, C.
    Krishnamurti, U.
    Mohanty, A.
    Liu, Y.
    Silverman, J. F.
    MODERN PATHOLOGY, 2014, 27 : 126A - 126A
  • [26] Is IHC for Fibulin-3 Specific for Malignant Mesothelioma in Effusion Cytology?
    Velosa, C.
    Krishnamurti, U.
    Mohanty, A.
    Liu, Y.
    Silverman, J. F.
    LABORATORY INVESTIGATION, 2014, 94 : 126A - 126A
  • [27] Diagnostic and prognostic utilities of humoral fibulin-3 in malignant pleural mesothelioma: Evidence from a meta-analysis
    Pei, Dongxu
    Li, Yongwei
    Liu, Xinwei
    Yan, Sha
    Guo, Xiaolan
    Xu, Xiaona
    Guo, Xiaoxia
    ONCOTARGET, 2017, 8 (08) : 13030 - 13038
  • [28] Malignant pleural mesothelioma (MPM): analysis of consecutive 100 patients
    El-Kasem, FA
    Gaafar, R
    Abdelrahman, AM
    Abdelbaki, H
    Hassan, N
    LUNG CANCER, 2004, 45 : S67 - S68
  • [29] Malignant pleural mesothelioma (MPM) in elderly patients: A multicenter survey
    Grosso, Federica
    Botta, Mario
    Zucali, Paolo Andrea
    Pasello, Giulia
    La Spina, Chiara Maria
    Roveta, Annalisa
    Perrino, Matteo
    Beretta, Giordano D.
    Polo, Valentina
    Santoro, Armando
    Favaretto, Adolfo G.
    Ceresoli, Giovanni Luca
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [30] Mesothelin as a marker of response in malignant pleural mesothelioma
    Wheatley-Price, P.
    Yang, B.
    Patel, D.
    Ma, C.
    Xu, W.
    Leighl, N.
    Feld, R.
    Cho, B.
    De Perrot, M.
    Liu, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345